Evidence Regarding Human Papillomavirus Testing in Secondary Prevention of Cervical Cancer
Evidence Regarding Human Papillomavirus Testing in Secondary Prevention of Cervical Cancer
About this item
Full title
Author / Creator
Publisher
Netherlands: Elsevier Ltd
Journal title
Language
English
Formats
Publication information
Publisher
Netherlands: Elsevier Ltd
Subjects
More information
Scope and Contents
Contents
Highlights ► In triage of LSIL, methods more specific than general hrHPV DNA tests may be preferred. ► To predict failure of treatment of high-grade cervical precancer, HPV tests are more sensitive than and as specific as cytology. ► In screening, a negative hrHPV DNA test is associated with a low future risk of precancer and cancer. ► HPV-screenin...
Alternative Titles
Full title
Evidence Regarding Human Papillomavirus Testing in Secondary Prevention of Cervical Cancer
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_swepub_primary_oai_swepub_ki_se_533040
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_swepub_primary_oai_swepub_ki_se_533040
Other Identifiers
ISSN
0264-410X
E-ISSN
1873-2518
DOI
10.1016/j.vaccine.2012.06.095
